Distinct interferon-gamma and interleukin-9 expression in cutaneous and oral lichen planus

Journal of the European Academy of Dermatology and Venereology

Volumn 31, Issue 5, 2017, Pages 880-886

  Weber, B ^a   Schlapbach, C ^a   Stuck, M ^b   Simon, H U ^b   Borradori, L ^a   Beltraminelli, H ^a   Simon, D ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CD123 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CD57 ANTIGEN; CD8 ANTIGEN; COMPLEMENT COMPONENT C3D RECEPTOR; FAS ANTIGEN; FAS LIGAND; GAMMA INTERFERON; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 22; INTERLEUKIN 23; INTERLEUKIN 6; INTERLEUKIN 9; T6 ANTIGEN; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR; BIOLOGICAL MARKER;

APOPTOSIS; ARTICLE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; EPITHELIUM CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE TEST; INFLAMMATION; LASER MICROSCOPY; LICHEN PLANUS; LYMPHOCYTIC INFILTRATION; NATURAL KILLER CELL; PLASMACYTOID DENDRITIC CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKIN BIOPSY; TH1 CELL; TH17 CELL; TH22 CELL; TH9 CELL; CD4+ T LYMPHOCYTE; METABOLISM; PATHOLOGY; RETROSPECTIVE STUDY;

APOPTOSIS; BIOMARKERS; CD4-POSITIVE T-LYMPHOCYTES; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-9; LICHEN PLANUS; LICHEN PLANUS, ORAL; RETROSPECTIVE STUDIES;

EID: 84991833019     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/jdv.13989     Document Type: Article

References (52)

1. Gorouhi F, Davari P, Fazel N. Cutaneous and mucosal lichen planus: comprehensive review of clinical subtypes, risk factors, diagnosis, and prognosis. ScientificWorldJournal 2014; 2014: 742826.
2. Bardellini E, Amadori F, Flocchini P, Bonadeo S, Majorana A. Clinicopathological features and malignant transformation of oral lichen planus: a 12-years retrospective study. Acta Odontol Scand 2013; 71: 834–840.
3. Crincoli V, Di Bisceglie MB, Scivetti M, Lucchese A, Tecco S, Festa F. Oral lichen planus: update on etiopathogenesis, diagnosis and treatment. Immunopharmacol Immunotoxicol 2011; 33: 11–20.
4. Farhi D, Dupin N. Pathophysiology, etiologic factors, and clinical management of oral lichen planus, part I: facts and controversies. Clin Dermatol 2010; 28: 100–108.
5. Wagner G, Rose C, Sachse MM. Clinical variants of lichen planus. J Dtsch Dermatol Ges 2013; 11: 309–319.
6. Santoro A, Majorana A, Bardellini E et al. Cytotoxic molecule expression and epithelial cell apoptosis in oral and cutaneous lichen planus. Am J Clin Pathol 2004; 121: 758–764.
7. Scully C, Beyli M, Ferreiro MC et al. Update on oral lichen planus: etiopathogenesis and management. Crit Rev Oral Biol Med 1998; 9: 86–122.
8. Lage D, Pimentel VN, Soares TC, Souza EM, Metze K, Cintra ML. Perforin and granzyme B expression in oral and cutaneous lichen planus - a comparative study. J Cutan Pathol 2011; 38: 973–978.
9. Roth N, Städler S, Lemann M, Hösli S, Simon HU, Simon D. Distinct eosinophil cytokine expression patterns in skin diseases - the possible existence of functionally different eosinophil subpopulations. Allergy 2011; 66: 1477–1486.
10. Simon D, Lindberg RL, Kozlowski E, Braathen LR, Simon HU. Epidermal caspase-3 cleavage associated with interferon-gamma-expressing lymphocytes in acute atopic dermatitis lesions. Exp Dermatol 2006; 15: 441–446.
11. Walker DM. Identification of subpopulations of lymphocytes and macrophages in the infiltrate of lichen planus lesions of skin and oral mucosa. Br J Dermatol 1976; 94: 529–534.
12. Flier J, Boorsma DM, van Beek PJ et al. Differential expression of CXCR3 targeting chemokines CXCL10, CXCL9, and CXCL11 in different types of skin inflammation. J Pathol 2001; 194: 398–405.
13. Khan A, Farah CS, Savage NW, Walsh LJ, Harbrow DJ, Sugerman PB. Th1 cytokines in oral lichen planus. J Oral Pathol Med 2003; 32: 77–83.
14. Fayyazi A, Schweyer S, Soruri A et al. T lymphocytes and altered keratinocytes express interferon-gamma and interleukin 6 in lichen planus. Arch Dermatol Res 1999; 291: 485–490.
15. Rhodus NL, Cheng B, Ondrey F. Th1/Th2 cytokine ratio in tissue transudates from patients with oral lichen planus. Mediators Inflamm 2007; 2007: 19854.
16. Yamamoto T, Osaki T. Characteristic cytokines generated by keratinocytes and mononuclear infiltrates in oral lichen planus. J Invest Dermatol 1995; 104: 784–788.
17. Schmitt E, Klein M, Bopp T. Th9 cells, new players in adaptive immunity. Trends Immunol 2014; 35: 61–68.
18. Neppelberg E, Johannessen AC, Jonsson R. Apoptosis in oral lichen planus. Eur J Oral Sci 2001; 109: 361–364.
19. Leverkus M, Yaar M, Gilchrest BA. Fas/Fas ligand interaction contributes to UV-induced apoptosis in human keratinocytes. Exp Cell Res 1997; 232: 255–262.
20. Carbone T, Nasorri F, Pennino D et al. CD56 highCD16 - NK cell involvement in cutaneous lichen planus. Eur J Dermatol 2010; 20: 724–730.
21. Gueiros LA, Gondak R, Jorge Júnior J et al. Increased number of Langerhans cells in oral lichen planus and oral lichenoid lesions. Oral Surg Oral Med Oral Pathol Oral Radiol 2012; 113: 661–666.
22. Mukae S, Okazaki Y, Tsuda H et al. Detection of fascin and CCR-7 positive mature dendritic cells in oral lichen planus. J Oral Pathol Med 2009; 38: 334–342.
23. Reddy DS, Sivapathasundharam B, Saraswathi TR, SriRam G. Evaluation of mast cells, eosinophils, blood capillaries in oral lichen planus and oral lichenoid mucositis. Indian J Dent Res 2012; 23: 695–696.
24. Hussein MR, Aboulhagag NM, Atta HS, Atta SM. Evaluation of the profile of the immune cell infiltrate in lichen planus, discoid lupus erythematosus, and chronic dermatitis. Pathology 2008; 40: 682–693.
25. Deguchi M, Aiba S, Ohtani H, Nagura H, Tagami H. Comparison of the distribution and numbers of antigen-presenting cells among T-lymphocyte-mediated dermatoses: CD1a+, factor XIIIa+, and CD68+ cells in eczematous dermatitis, psoriasis, lichen planus and graft-versus-host disease. Arch Dermatol Res 2002; 294: 297–302.
26. Shimizu M, Higaki Y, Higaki M, Kawashima M. The role of granzyme B-expressing CD8-positive T cells in apoptosis of keratinocytes in lichen planus. Arch Dermatol Res 1997; 289: 527–532.
27. Sugerman PB, Satterwhite K, Bigby M. Auto-cytotoxic T cell clones in lichen planus. Br J Dermatol 2000; 142: 449–456.
28. Parolini S, Santoro A, Marcenaro E et al. The role of chemerin in the colocalization of NK and dendritic cell subsets into inflamed tissues. Blood 2007; 109: 3625–3632.
29. Cinrad C, Meller S, Gilliet M. Plasmacytoid dendritic cells in the skin: to sense or not to sense nucleic acids. Semin Immunol 2009; 21: 101–109.
30. Gaffen SL, Jain R, Garg AV, Cua DJ. The IL-23-IL-17 immune axis: from mechanisms to therapeutic testing. Nat Rev Immunol 2014; 14: 585–600.
31. Lu R, Zhang J, Sun W, Du G, Zhou G. Inflammation-related cytokines in oral lichen planus: an overview. J Oral Pathol Med 2015; 44: 1–14.
32. Chen J, Feng J, Chen X et al. Immunoexpression of interleukin-22 and interleukin-23 in oral and cutaneous lichen planus lesions: a preliminary study. Mediators Inflamm 2013; 2013: 801974.
33. Nikoopour E, Bellemore SM, Singh B. IL-22, cell regeneration and autoimmunity. Cytokine 2015; 74: 35–42.
34. Ma HL, Liang S, Li J et al. IL-22 is required for Th17 cell-mediated pathology in a mouse model of psoriasis-like skin inflammation. J Clin Invest 2008; 118: 597–607.
35. Burkett PR, Meyer zur Hoste G, Kuchroo VK. Pouring fuel on the fire: T cells, the environment and autoimmunity. J Clin Invest 2015; 125: 2211–2219.
36. Shen Z, Gao X, Ma L, Zhou Z, Shen X, Liu W. Expression of Foxp3 and interleukin-17 in lichen planus lesions with emphasis on difference in oral and cutaneous variants. Arch Dermatol Res 2014; 306: 441–446.
37. Firth FA, Friedlander LT, Parachuru VP, Kardos TB, Seymour GJ, Rich AM. Regulation of immune cells in oral lichen planus. Arch Dermatol Res 2015; 307: 333–339.
38. Isailovic N, Daigo K, Mantovani A, Selmi C. Interleukin-17 and innate immunity in infections and chronic inflammation. J Autoimmun 2015; 60: 1–11.
39. Papp KA, Leonardi C, Menter A et al. Brodalumab, an anti-interleukin-17-receptor antibody for psoriasis. N Engl J Med 2012; 366: 1181–1189.
40. Leonardi CL, Kimball AB, Papp KA et al. PHOENIX 1 study investigators. Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 1). Lancet 2008; 371: 1665–1674.
41. Purwar R, Schlapbach C, Xiao S et al. Robust tumor immunity to melanoma mediated by interleukin-9-producing T cells. Nat Med 2012; 18: 1248–1253.
42. Licona-Limón P, Henao-Mejia J, Temann AU et al. Th9 cells drive host immunity against gastrointestinal worm infection. Immunity 2013; 39: 744–757.
43. Nalleweg N, Chiriac MT, Podstawa E et al. IL-9 and its receptor are predominantly involved in the pathogenesis of UC. Gut 2015; 64: 743–755.
44. Kearley J, Erjefalt JS, Andersson C et al. IL-9 governs allergen-induced mast cell numbers in the lung and chronic remodeling of the airways. Am J Respir Crit Care Med 2011; 183: 865–875.
45. Schlapbach C, Gehad A, Yang C et al. Human TH9 cells are skin-tropic and have autocrine and paracrine proinflammatory capacity. Sci Transl Med 2014; 6: 219ra8.
46. Zhou Y, Sonobe Y, Akahori T et al. IL-9 promotes Th17 cell migration into the central nervous system via CC chemokine ligand-20 produced by astrocytes. J Immunol 2011; 186: 4415–4421.
47. Lu Y, Hong S, Li H et al. Th9 cells promote antitumor immune responses in vivo. J Clin Invest 2012; 122: 4160–4171.
48. Hashimoto K. Apoptosis in lichen planus and several other dermatoses. Intra-epidermal cell death with filamentous degeneration. Acta Derm Venereol 1976; 56: 187–210.
49. Dekker NP, Lozada-Nur F, Lagenaur LA, MacPhail LA, Bloom CY, Regezi JA. Apoptosis-associated markers in oral lichen planus. J Oral Pathol Med 1997; 26: 170–175.
50. Sklavounou-Andrikopoulou A, Chrysomali E, Iakovou M, Garinis GA, Karameris A. Elevated serum levels of the apoptosis related molecules TNF-alpha, Fas/Apo-1 and Bcl-2 in oral lichen planus. J Oral Pathol Med 2004; 33: 386–390.
51. Takahashi H, Kouno M, Nagao K et al. Desmoglein 3-specific CD4+ T cells induce pemphigus vulgaris and interface dermatitis in mice. J Clin Invest 2011; 121: 3677–3688.
52. Mattila R, Syrjänen S. Caspase cascade pathways in apoptosis of oral lichen planus. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2010; 110: 618–623.